Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
Cetrimide, or alkyltrimethylammonium bromide, is an antiseptic which is a mixture of three quaternary ammonium compounds: tetradonium bromide (TTAB or MITMAB), cetrimonium bromide (CTAB), and laurtrimonium bromide (DTAB or LTAB). It was first discovered and developed by ICI and introduced under the brand name Cetavlon. It is used as a 1-3 % solution for cleaning roadside accident wounds. ICI also introduced Savlon, which was a combination of cetrimide and chlorhexidine. ICI later sold the Savlon brand OTC to Johnson & Johnson in May 1992. Cetrimide is used in various applications such as antiseptic agents, diagnostic test and analysis, topical formulations, and dental treatment.
- Council of Europe (2007). European Pharmacopoeia (Ph. Eur.) (6.0 ed.). Strasbourg: The Stationery Office. pp. 1484–5. ISBN 978-92-871-6054-6. OCLC 170932841.
- "Newspaper Article - Page 11 Advertisements Column 1". Archived from the original on 2013-10-05. Retrieved 2013-08-15.
- Tripathi, KD. Essentials of Medical Pharmacology (7th ed.). p. 900.
- "JOHNSON & JOHNSON ACQUIRES SAVLON OTC BRANDS FROM ICI - Free Online Library". Archived from the original on 2013-10-05.
- "Cetrimide Applications". 22 October 2021. Archived from the original on 2019-04-05.